Direct chemogenetic control of heterotrimeric G protein signaling
异源三聚体 G 蛋白信号传导的直接化学遗传学控制
基本信息
- 批准号:10590217
- 负责人:
- 金额:$ 45.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-01 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:Adenylate CyclaseAdoptedAffinityAgreementAntiviral AgentsBindingBiological AssayBiological ProcessBioluminescenceBiosensorCell LineCell Surface ReceptorsCell physiologyCellsChemicalsClinicalCommunicationCommunitiesCyclic AMPDiseaseDrug TargetingEnergy TransferEngineeringEtiologyEventFDA approvedFamilyG Protein-Coupled Receptor SignalingG-Protein-Coupled ReceptorsGTP BindingGTP-Binding Protein alpha Subunits, GsGTP-Binding ProteinsGeneticGoalsGuanosine TriphosphateHepatitis CHeterotrimeric G Protein SubunitHeterotrimeric GTP-Binding ProteinsHormonesIon ChannelLeftLengthLigandsLocationMammalian CellMeasuresMediatingMethodsMusNamesNeuronsNeurosciencesNeurotransmitter ReceptorNeurotransmittersOpticsOutcomeOutputPathologicPeptidesPerformancePharmaceutical PreparationsPharmacologyPhospholipase CPhotonsPhysiologicalPhysiological ProcessesProteinsReceptor ActivationRegulationResearchResearch PersonnelRoleSecond Messenger SystemsSignal TransductionSignaling ProteinSpecificityStimulusTechnologyTherapeuticTransducersbasedesignexperimental studyhuman diseaseimprovednervous system disorderneuropsychiatric disorderneuroregulationneurotransmissionnew technologynovelperformance testsprotein activationreceptorreceptor-mediated signalingresponsesubcellular targetingtool
项目摘要
ABSTRACT
SIGNIFICANCE: G protein-coupled receptors (GPCRs) initiate cellular responses to many different stimuli, like
neurotransmitters, hormones or photons. They are critical for many physiological processes and their
dysregulation frequently leads to human disease, which is also in agreement with the fact that >30% of FDA-
approved drugs target GPCRs. GPCRs are key pharmacological targets in neurological and neuropsychiatric
diseases based on their function as metabotropic neurotransmitter receptors with a prominent role in
neuromodulation. The main mechanism of action of GPCRs is through activation of heterotrimeric G proteins,
which are broadly divided in 4 families (Gs, Gi/o, Gq/11, G12/13). However, the mechanisms and consequences of
heterotrimeric G protein signaling have been difficult to elucidate because of the lack of adequate experimental
tools to manipulate their activity with high precision and specificity in a cellular context. Our goal is to develop a
new class of chemogenetic tool to directly activate heterotrimeric G proteins without perturbing GPCRs or other
cellular processes. Chemogenetics, in general, refers to a method by which a protein is engineered to interact
with previously unrecognized chemical compounds. The tools to be developed here will allow investigators in
this field of research to manipulate and dissect the functional consequences of G protein activation with
unprecedented precision, thereby revealing fundamental mechanisms that underlie physiological, pathological,
or therapeutic modulation of neurotransmitter responses and other biological processes.
BACKGROUND: Upon stimulation, GPCRs promote GTP loading on the Gα-subunit of heterotrimeric G
proteins (Gαβγ). In turn, Gα-GTP binds to effector proteins to propagate signaling. In the context of
neurotransmission, Gα proteins of the Gs (e.g., Gαs) or the Gq/11 (e.g., Gαq) family are primarily
neurostimulatory by virtue of their ability to increase cAMP or intracellular Ca2+, respectively. In contrast, Gα
proteins of the Gi/o family (e.g., Gαi) cause neuroinhibition via suppression of cAMP. These effects are
mediated through direct binding to and modulation of effector proteins that control second messenger levels—
i.e., adenylyl cyclases for Gαs and Gαi, or phospholipases C for Gαq. Gβγ also contributes to neuromodulation
through the regulation of ion channels. We have envisioned and partially validated a chemogenetic approach
to achieve the direct and specific activation of G proteins without the need of GPCRs.
SYNOPSIS OF AIMS: In Aim 1, we will identify the components required to engineer Gαi, Gαs, Gαq, or Gβγ
proteins that are activated by chemical compounds that do not have known targets or effects in mammalian
cells. These constructs will be evaluated by using optical biosensors that directly detect active G proteins. In
Aim 2, we will test the performance of these chemically-activated G proteins by using downstream signaling
readouts directly dependent on cognate G protein effectors in cell lines and in neuronal primary cultures.
.
抽象的
意义:G 蛋白偶联受体 (GPCR) 启动细胞对许多不同刺激的反应,例如
神经递质、激素或光子。它们对于许多生理过程及其作用至关重要
失调经常导致人类疾病,这也与 > 30% 的 FDA-
已批准的药物以 GPCR 为靶点。 GPCR 是神经病学和神经精神病学的关键药理学靶点
基于其作为代谢型神经递质受体的功能的疾病,在
神经调节。 GPCR 的主要作用机制是通过激活异源三聚体 G 蛋白,
它们大致分为 4 个家族(Gs、Gi/o、Gq/11、G12/13)。然而,其机制和后果
由于缺乏足够的实验数据,异三聚体 G 蛋白信号传导一直难以阐明。
在细胞环境中以高精度和特异性操纵其活动的工具。我们的目标是开发一个
新型化学遗传学工具,可直接激活异源三聚体 G 蛋白,而不干扰 GPCR 或其他
细胞过程。一般来说,化学遗传学是指一种将蛋白质改造为相互作用的方法
与以前未被识别的化合物。这里开发的工具将使研究人员能够
这一研究领域旨在操纵和剖析 G 蛋白激活的功能后果
前所未有的精度,从而揭示生理、病理、
或神经递质反应和其他生物过程的治疗调节。
背景:刺激后,GPCR 会促进异源三聚体 G 的 Gα 亚基上的 GTP 负载
蛋白质(Gαβγ)。反过来,Gα-GTP 与效应蛋白结合以传播信号传导。在这样的背景下
在神经传递中,Gs(例如 Gαs)或 Gq/11(例如 Gαq)家族的 Gα 蛋白主要是
由于它们分别增加 cAMP 或细胞内 Ca2+ 的能力而具有神经刺激作用。相比之下,Gα
Gi/o 家族蛋白(例如 Gαi)通过抑制 cAMP 引起神经抑制。这些效果是
通过直接结合和调节控制第二信使水平的效应蛋白来介导——
即 Gαs 和 Gαi 的腺苷酸环化酶,或 Gαq 的磷脂酶 C。 Gβγ 也有助于神经调节
通过离子通道的调节。我们设想并部分验证了化学遗传学方法
无需GPCR即可实现G蛋白的直接特异性激活。
目标概要:在目标 1 中,我们将确定设计 Gαi、Gαs、Gαq 或 Gβγ 所需的组件
由在哺乳动物中没有已知靶标或作用的化合物激活的蛋白质
细胞。这些构建体将通过使用直接检测活性 G 蛋白的光学生物传感器进行评估。在
目标 2,我们将通过使用下游信号传导来测试这些化学激活的 G 蛋白的性能
读数直接依赖于细胞系和神经元原代培养物中的同源 G 蛋白效应器。
。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mikel Garcia-Marcos其他文献
Mikel Garcia-Marcos的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mikel Garcia-Marcos', 18)}}的其他基金
Versatile and high-fidelity optical biosensor platforms for GPCR signaling
用于 GPCR 信号传导的多功能高保真光学生物传感器平台
- 批准号:
10679863 - 财政年份:2023
- 资助金额:
$ 45.38万 - 项目类别:
Non-canonical activation of heterotrimeric G protein signaling in vivo
异源三聚体 G 蛋白信号传导的体内非典型激活
- 批准号:
10220082 - 财政年份:2019
- 资助金额:
$ 45.38万 - 项目类别:
Non-canonical activation of heterotrimeric G protein signaling in vivo
异源三聚体 G 蛋白信号传导的体内非典型激活
- 批准号:
10461747 - 财政年份:2019
- 资助金额:
$ 45.38万 - 项目类别:
Non-canonical activation of heterotrimeric G protein signaling in vivo
异源三聚体 G 蛋白信号传导的体内非典型激活
- 批准号:
9914590 - 财政年份:2019
- 资助金额:
$ 45.38万 - 项目类别:
Non-canonical activation of heterotrimeric G protein signaling in vivo
异源三聚体 G 蛋白信号传导的体内非典型激活
- 批准号:
10018921 - 财政年份:2019
- 资助金额:
$ 45.38万 - 项目类别:
Non-canonical activation of heterotrimeric G protein signaling in vivo
异源三聚体 G 蛋白信号传导的体内非典型激活
- 批准号:
10581960 - 财政年份:2019
- 资助金额:
$ 45.38万 - 项目类别:
Targeting of non-canonical G protein signaling with small molecules
用小分子靶向非经典 G 蛋白信号传导
- 批准号:
10180984 - 财政年份:2018
- 资助金额:
$ 45.38万 - 项目类别:
Next generation G protein activity biosensors
下一代 G 蛋白活性生物传感器
- 批准号:
9789949 - 财政年份:2018
- 资助金额:
$ 45.38万 - 项目类别:
Identification of chemical probes that specifically disrupt the GIV-Gi interface
鉴定特异性破坏 GIV-Gi 界面的化学探针
- 批准号:
8986801 - 财政年份:2015
- 资助金额:
$ 45.38万 - 项目类别:
Alternative mechanisms of signaling via trimeric G proteins
通过三聚体 G 蛋白传递信号的替代机制
- 批准号:
10374905 - 财政年份:2014
- 资助金额:
$ 45.38万 - 项目类别:
相似海外基金
How novices write code: discovering best practices and how they can be adopted
新手如何编写代码:发现最佳实践以及如何采用它们
- 批准号:
2315783 - 财政年份:2023
- 资助金额:
$ 45.38万 - 项目类别:
Standard Grant
One or Several Mothers: The Adopted Child as Critical and Clinical Subject
一位或多位母亲:收养的孩子作为关键和临床对象
- 批准号:
2719534 - 财政年份:2022
- 资助金额:
$ 45.38万 - 项目类别:
Studentship
A comparative study of disabled children and their adopted maternal figures in French and English Romantic Literature
英法浪漫主义文学中残疾儿童及其收养母亲形象的比较研究
- 批准号:
2633211 - 财政年份:2020
- 资助金额:
$ 45.38万 - 项目类别:
Studentship
A material investigation of the ceramic shards excavated from the Omuro Ninsei kiln site: Production techniques adopted by Nonomura Ninsei.
对大室仁清窑遗址出土的陶瓷碎片进行材质调查:野野村仁清采用的生产技术。
- 批准号:
20K01113 - 财政年份:2020
- 资助金额:
$ 45.38万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A comparative study of disabled children and their adopted maternal figures in French and English Romantic Literature
英法浪漫主义文学中残疾儿童及其收养母亲形象的比较研究
- 批准号:
2436895 - 财政年份:2020
- 资助金额:
$ 45.38万 - 项目类别:
Studentship
A comparative study of disabled children and their adopted maternal figures in French and English Romantic Literature
英法浪漫主义文学中残疾儿童及其收养母亲形象的比较研究
- 批准号:
2633207 - 财政年份:2020
- 资助金额:
$ 45.38万 - 项目类别:
Studentship
The limits of development: State structural policy, comparing systems adopted in two European mountain regions (1945-1989)
发展的限制:国家结构政策,比较欧洲两个山区采用的制度(1945-1989)
- 批准号:
426559561 - 财政年份:2019
- 资助金额:
$ 45.38万 - 项目类别:
Research Grants
Securing a Sense of Safety for Adopted Children in Middle Childhood
确保被收养儿童的中期安全感
- 批准号:
2236701 - 财政年份:2019
- 资助金额:
$ 45.38万 - 项目类别:
Studentship
A Study on Mutual Funds Adopted for Individual Defined Contribution Pension Plans
个人设定缴存养老金计划采用共同基金的研究
- 批准号:
19K01745 - 财政年份:2019
- 资助金额:
$ 45.38万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Structural and functional analyses of a bacterial protein translocation domain that has adopted diverse pathogenic effector functions within host cells
对宿主细胞内采用多种致病效应功能的细菌蛋白易位结构域进行结构和功能分析
- 批准号:
415543446 - 财政年份:2019
- 资助金额:
$ 45.38万 - 项目类别:
Research Fellowships














{{item.name}}会员




